• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本农村地区两家三级医院2010年代后期急性冠状动脉综合征患者中期预后事件的发生率——一项时间比较研究

Incidence of Mid-Term Prognostic Events in Patients With Acute Coronary Syndrome During the Late 2010s in 2 Tertiary Hospitals in a Rural Area of Japan - A Temporal Comparison.

作者信息

Yasuda Yu, Ishiguchi Hironori, Yamaguchi Madoka, Murakami Kei, Kinoshita Natsu, Kato Takayoshi, Yoshida Masaaki, Imoto Koji, Sonoyama Kazuhiko, Kawabata Tetsuya, Okamura Takayuki, Endo Akihiro, Kobayashi Shigeki, Yano Masafumi, Oda Tsuyoshi, Tanabe Kazuaki

机构信息

Division of Cardiology, Shimane University Faculty of Medicine Izumo Japan.

Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Ube Japan.

出版信息

Circ Rep. 2023 Apr 20;5(5):198-209. doi: 10.1253/circrep.CR-23-0029. eCollection 2023 May 10.

DOI:10.1253/circrep.CR-23-0029
PMID:37180477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10166665/
Abstract

Data on the incidence of mid-term prognostic events in patients who developed acute coronary syndrome (ACS) in the late 2010s are scarce. We retrospectively included and collected data for 889 patients with ACS (ST-elevation myocardial infarction [STEMI]/non-ST-elevation ACS [NSTE-ACS]) discharged alive from 2 tertiary hospitals in Izumo City, in rural Japan, between August 2009 and July 2018. Patients were divided into 3 time groups (T1: August 2009-July 2012; T2: August 2012-July 2015; T3: August 2015-July 2018). The cumulative incidence of major adverse cardiovascular events (MACE; comprising all-cause death, recurrent ACS, and stroke), major bleeding, and heart failure hospitalization within 2 years of discharge was compared among the 3 groups. The incidence of freedom from MACE was significantly higher in the T3 group than in the T1 and T2 groups (93 [95% confidence interval {CI} 90-96%] vs. 86% [95% CI 83-90] and 89% [95% CI 90-96], respectively; P=0.03). There was a tendency for a higher incidence of STEMI among patients in T3 (P=0.057). The incidence of NSTE-ACS was comparable among the 3 groups (P=0.31), as was the incidence of major bleeding and hospitalization for heart failure. The incidence of mid-term MACE in patients who developed ACS during the late 2010 s (2015-2018) was lower than that in prior periods (2009-2015).

摘要

关于2010年代后期发生急性冠状动脉综合征(ACS)患者中期预后事件发生率的数据稀缺。我们回顾性纳入并收集了2009年8月至2018年7月期间从日本农村出云市的2家三级医院存活出院的889例ACS患者(ST段抬高型心肌梗死[STEMI]/非ST段抬高型ACS[NSTE-ACS])的数据。患者被分为3个时间段组(T1:2009年8月至2012年7月;T2:2012年8月至2015年7月;T3:2015年8月至2018年7月)。比较了3组患者出院后2年内主要不良心血管事件(MACE;包括全因死亡、复发性ACS和中风)、大出血和心力衰竭住院的累积发生率。T3组无MACE的发生率显著高于T1组和T2组(分别为93[95%置信区间{CI}90 - 96%] vs. 86%[95%CI 83 - 90]和89%[95%CI 90 - 96];P = 0.03)。T3组患者中STEMI的发生率有升高趋势(P = 0.057)。3组之间NSTE-ACS的发生率相当(P = 0.31),大出血和心力衰竭住院的发生率也是如此。2010年代后期(2015 - 2018年)发生ACS患者的中期MACE发生率低于先前时期(2009 - 2015年)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7173/10166665/72454767d8c1/circrep-5-198-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7173/10166665/2552a00f7c3e/circrep-5-198-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7173/10166665/65524995a302/circrep-5-198-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7173/10166665/f900abe26e27/circrep-5-198-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7173/10166665/72454767d8c1/circrep-5-198-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7173/10166665/2552a00f7c3e/circrep-5-198-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7173/10166665/65524995a302/circrep-5-198-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7173/10166665/f900abe26e27/circrep-5-198-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7173/10166665/72454767d8c1/circrep-5-198-g004.jpg

相似文献

1
Incidence of Mid-Term Prognostic Events in Patients With Acute Coronary Syndrome During the Late 2010s in 2 Tertiary Hospitals in a Rural Area of Japan - A Temporal Comparison.日本农村地区两家三级医院2010年代后期急性冠状动脉综合征患者中期预后事件的发生率——一项时间比较研究
Circ Rep. 2023 Apr 20;5(5):198-209. doi: 10.1253/circrep.CR-23-0029. eCollection 2023 May 10.
2
Long-term clinical outcomes in patients with non-ST-segment Elevation Acute Coronary Syndrome and ST-segment elevation myocardial infarction with thrombolysis in myocardial infarction 0 flow.非ST段抬高型急性冠状动脉综合征和ST段抬高型心肌梗死伴心肌梗死溶栓0级血流患者的长期临床结局
Int J Cardiol Heart Vasc. 2023 Aug 29;48:101254. doi: 10.1016/j.ijcha.2023.101254. eCollection 2023 Oct.
3
Japanese postmarketing surveillance of clopidogrel in patients with non-ST-segment elevation acute coronary syndrome, stable angina, old myocardial infarction, and ST-segment elevation myocardial infarction after percutaneous coronary intervention in a real-life setting: the final report (J-PLACE Final).氯吡格雷在非ST段抬高型急性冠状动脉综合征、稳定型心绞痛、陈旧性心肌梗死以及经皮冠状动脉介入治疗后的ST段抬高型心肌梗死患者中的日本上市后真实世界监测:最终报告(J-PLACE最终报告)
Cardiovasc Interv Ther. 2016 Apr;31(2):101-13. doi: 10.1007/s12928-015-0355-z. Epub 2015 Oct 8.
4
[Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome].[髓过氧化物酶浓度在急性冠状动脉综合征患者中的预后价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Apr 24;46(4):284-291. doi: 10.3760/cma.j.issn.0253-3758.2018.04.007.
5
Trends Over Time in the Incidences of ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction During the Past Decade in a Rural Japanese High-Aged Population.在过去十年中,日本农村高龄人群中 ST 段抬高型心肌梗死和非 ST 段抬高型心肌梗死的发病率变化趋势。
Circ J. 2021 Jan 25;85(2):175-184. doi: 10.1253/circj.CJ-20-0955. Epub 2021 Jan 13.
6
Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.稳定性缺血性心脏病、非ST段抬高型急性冠状动脉综合征和ST段抬高型心肌梗死患者复发性缺血事件的风险及发生时间。
Am Heart J. 2016 May;175:56-65. doi: 10.1016/j.ahj.2016.01.021. Epub 2016 Feb 23.
7
[Dynamic changes of complement level in patients with acute coronary syndrome and its relationships with myocardial injury].急性冠状动脉综合征患者补体水平的动态变化及其与心肌损伤的关系
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Jun;29(6):515-519. doi: 10.3760/cma.j.issn.2095-4352.2017.06.008.
8
Prognostic implications of non-infarct-related territory unrecognized myocardial infarction in patients with non-ST-segment-elevation acute coronary syndrome.非 ST 段抬高型急性冠状动脉综合征患者中未识别的非梗死相关区域心肌梗死的预后意义。
J Cardiol. 2023 Dec;82(6):433-440. doi: 10.1016/j.jjcc.2023.06.007. Epub 2023 Jun 20.
9
Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.经桡动脉与股动脉入路在急性冠状动脉综合征伴或不伴 ST 段抬高患者中的比较。
Eur Heart J. 2017 Apr 7;38(14):1069-1080. doi: 10.1093/eurheartj/ehx048.
10
Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: A systematic review and network meta-analysis.ST 段抬高型心肌梗死和非 ST 段抬高型急性冠脉综合征患者的双联抗血小板治疗策略:系统评价和网络荟萃分析。
Int J Cardiol. 2023 Oct 15;389:131157. doi: 10.1016/j.ijcard.2023.131157. Epub 2023 Jul 9.

引用本文的文献

1
Post-discharge major bleeding/all-cause death in acute coronary syndrome: academic research consortium criteria versus Japan-specific criteria.急性冠状动脉综合征出院后大出血/全因死亡:学术研究联盟标准与日本特定标准对比
BMC Cardiovasc Disord. 2025 May 15;25(1):370. doi: 10.1186/s12872-025-04834-1.

本文引用的文献

1
Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort study.过去二十年接受冠状动脉血运重建的 ST 段抬高型心肌梗死患者的人口统计学、临床实践和长期结局变化:队列研究。
BMJ Open. 2021 Mar 31;11(3):e043683. doi: 10.1136/bmjopen-2020-043683.
2
Incidence and Demographic Trends for Acute Coronary Syndrome in a Non-Epidemic Area During the Coronavirus Disease Pandemic in Japan - A 2-Institutional Observational Study.日本新冠疫情期间非流行地区急性冠脉综合征的发病率及人口统计学趋势——一项双机构观察性研究
Circ Rep. 2021 Jan 20;3(2):95-99. doi: 10.1253/circrep.CR-20-0141.
3
Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3.
在过去的二十年中,非 ST 段抬高型急性冠状动脉综合征患者的人口统计学、实践模式和长期预后:CREDO-Kyoto 队列-2 和队列-3。
BMJ Open. 2021 Feb 22;11(2):e044329. doi: 10.1136/bmjopen-2020-044329.
4
Trends Over Time in the Incidences of ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction During the Past Decade in a Rural Japanese High-Aged Population.在过去十年中,日本农村高龄人群中 ST 段抬高型心肌梗死和非 ST 段抬高型心肌梗死的发病率变化趋势。
Circ J. 2021 Jan 25;85(2):175-184. doi: 10.1253/circj.CJ-20-0955. Epub 2021 Jan 13.
5
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
6
Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study.丹麦新冠疫情封锁前后新发和恶化心力衰竭的发生率:一项全国性队列研究。
Circ Heart Fail. 2020 Jun;13(6):e007274. doi: 10.1161/CIRCHEARTFAILURE.120.007274. Epub 2020 Jun 2.
7
Guideline adherence and long-term clinical outcomes in patients with acute myocardial infarction: a Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) substudy.日本通用定义诊断急性心肌梗死注册研究(J-MINUET)亚研究:急性心肌梗死患者的指南依从性与长期临床结局。
Eur Heart J Acute Cardiovasc Care. 2020 Dec;9(8):939-947. doi: 10.1177/2048872620902024. Epub 2020 Jan 24.
8
Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United States.美国老年人急性心肌梗死 20 年转归趋势。
JAMA Netw Open. 2019 Mar 1;2(3):e191938. doi: 10.1001/jamanetworkopen.2019.1938.
9
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.依洛尤单抗与急性冠脉综合征后的心血管结局。
N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.
10
Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial.药物洗脱支架置入术后 ST 段抬高型心肌梗死(DAPT-STEMI)患者 6 个月与 12 个月双联抗血小板治疗:随机、多中心、非劣效性试验。
BMJ. 2018 Oct 2;363:k3793. doi: 10.1136/bmj.k3793.